Association Study of the HTR2C, Leptin and Adiponectin Genes and Serum Marker Analyses in Clozapine Treated Long-Term Patients with Schizophrenia

[1]  B. Bogerts,et al.  Investigation of molecular serum profiles associated with predisposition to antipsychotic-induced weight gain , 2015, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[2]  O. Kampman,et al.  Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine , 2014, Psychiatry Research.

[3]  J. Kennedy,et al.  Pharmacogenetics of Antipsychotics , 2014, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[4]  V. Mohan,et al.  Genetic association of ADIPOQ gene variants with type 2 diabetes, obesity and serum adiponectin levels in south Indian population. , 2013, Gene.

[5]  N. Geary,et al.  Sex differences in the physiology of eating. , 2013, American journal of physiology. Regulatory, integrative and comparative physiology.

[6]  Y. Lee,et al.  Pathway analysis of a genome-wide association study in schizophrenia. , 2013, Gene.

[7]  Yujie Zhou,et al.  Common variants in adiponectin gene are associated with coronary artery disease and angiographical severity of coronary atherosclerosis in type 2 diabetes , 2013, Cardiovascular Diabetology.

[8]  A. D'Angelo,et al.  Adipocytokine Levels in Obese and Non-obese Subjects: an Observational Study , 2013, Inflammation.

[9]  M. A. Lasunción,et al.  Atypical antipsychotics alter cholesterol and fatty acid metabolism in vitro[S] , 2013, Journal of Lipid Research.

[10]  J. Lieberman,et al.  Association of a Functional Polymorphism in Neuropeptide Y With Antipsychotic-Induced Weight Gain in Schizophrenia Patients , 2013, Journal of clinical psychopharmacology.

[11]  S. Costantini,et al.  Functional and structural features of adipokine family. , 2013, Cytokine.

[12]  D. Cohen,et al.  Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome , 2012, Psychoneuroendocrinology.

[13]  A. Andreasson,et al.  Leptin and adiponectin: Distribution and associations with cardiovascular risk factors in men and women of the general population , 2012, American journal of human biology : the official journal of the Human Biology Council.

[14]  Xiang Li,et al.  Association of the adiponectin gene rs1501299 G>T variant, serum adiponectin levels, and the risk of coronary artery disease in a Chinese population. , 2012, Diabetes research and clinical practice.

[15]  J. Lieberman,et al.  Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[16]  R. Conley,et al.  Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia. , 2012, The Journal of clinical psychiatry.

[17]  O. Kwon,et al.  Inhibition of mouse brown adipocyte differentiation by second-generation antipsychotics , 2012, Experimental & Molecular Medicine.

[18]  H. Harwood,et al.  The adipocyte as an endocrine organ in the regulation of metabolic homeostasis , 2012, Neuropharmacology.

[19]  N. Fukui,et al.  Dysregulation of Adipocytokines Related to Second-Generation Antipsychotics in Normal Fasting Glucose Patients With Schizophrenia , 2012, Journal of clinical psychopharmacology.

[20]  D. Gu,et al.  Association between polymorphisms in the adiponectin gene and cardiovascular disease: a meta-analysis , 2012, BMC Medical Genetics.

[21]  M. Monda,et al.  The Role of Leptin in Antipsychotic-Induced Weight Gain: Genetic and Non-Genetic Factors , 2012, Journal of obesity.

[22]  F. Paccaud,et al.  Sex difference and the role of leptin in the association between high-sensitivity C-reactive protein and adiposity in two different populations , 2012, European Journal of Epidemiology.

[23]  J. Kulkarni,et al.  The Role of Oestrogen and Other Hormones in the Pathophysiology and Treatment of Schizophrenia , 2012, Schizophrenia research and treatment.

[24]  D. Cohen,et al.  Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study , 2010, The Pharmacogenomics Journal.

[25]  Xi-rong Guo,et al.  Genetic Polymorphisms in Adipokine Genes and the Risk of Obesity: A Systematic Review and Meta‐Analysis , 2012, Obesity.

[26]  J. Reginster,et al.  Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: Results from a 3-month prospective open-label study , 2011, European Neuropsychopharmacology.

[27]  Y. Tsai,et al.  Polymorphisms of INSIG2, MC4R, and LEP Are Associated With Obesity- and Metabolic-Related Traits in Schizophrenic Patients , 2011, Journal of clinical psychopharmacology.

[28]  M. Arranz,et al.  Pharmacogenetics of Response to Antipsychotics in Patients with Schizophrenia , 2011, CNS drugs.

[29]  J. Suvisaari,et al.  Inflammation in psychotic disorders: A population-based study , 2011, Psychiatry Research.

[30]  Jing-ping Zhao,et al.  Genetic predictors of antipsychotic-induced weight gain: a case-matched multi-gene study. , 2011, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences.

[31]  T. Egberts,et al.  Polymorphisms of the LEP, LEPR and HTR2C gene: obesity and BMI change in patients using antipsychotic medication in a naturalistic setting. , 2011, Pharmacogenomics.

[32]  W. Pan,et al.  Adiponectin Gene Polymorphism Is Selectively Associated with the Concomitant Presence of Metabolic Syndrome and Essential Hypertension , 2011, PloS one.

[33]  Kuo Sm,et al.  Lack of association between body mass index and plasma adiponectin levels in healthy adults. , 2011 .

[34]  J. Hebebrand,et al.  Association Study of Energy Homeostasis Genes and Antipsychotic-Induced Weight Gain in Patients with Schizophrenia , 2010, Pharmacopsychiatry.

[35]  S. Kuo,et al.  Lack of association between body mass index and plasma adiponectin levels in healthy adults , 2011, International Journal of Obesity.

[36]  J. Tuomilehto,et al.  Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study , 2011, BMC Medical Genetics.

[37]  J. Lieberman,et al.  Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysis. , 2010, Pharmacogenomics.

[38]  T. Egberts,et al.  Combined HTR2C-LEP Genotype as a Determinant of Obesity in Patients Using Antipsychotic Medication , 2010, Journal of clinical psychopharmacology.

[39]  G. Venkatasubramanian,et al.  A Longitudinal Study on the Impact of Antipsychotic Treatment on Serum Leptin in Schizophrenia , 2010, Clinical neuropharmacology.

[40]  D. Clegg,et al.  Central effects of estradiol in the regulation of food intake, body weight, and adiposity , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[41]  D. Müller,et al.  Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample. , 2010, Pharmacogenomics.

[42]  B. Gustafson.  Adipose tissue, inflammation and atherosclerosis. , 2010, Journal of atherosclerosis and thrombosis.

[43]  David M. Evans,et al.  Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. , 2010, Atherosclerosis.

[44]  R. Judd,et al.  The influence of sex, body composition, and nonesterified fatty acids on serum adipokine concentrations. , 2009, Metabolism: clinical and experimental.

[45]  Jingping Zhao,et al.  Adiponectin gene +45T/G and +276G/T polymorphism and antipsychotic-induced weight gain. , 2009, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences.

[46]  Deborah J. Clegg,et al.  Sexual differences in the control of energy homeostasis , 2009, Frontiers in Neuroendocrinology.

[47]  Lise Getoor,et al.  Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia , 2009, Schizophrenia Research.

[48]  B. Franke,et al.  HTR2C Gene Polymorphisms and the Metabolic Syndrome in Patients With Schizophrenia: A Replication Study , 2009, Journal of clinical psychopharmacology.

[49]  A. Egberts,et al.  Polymorphisms of the LEP- and LEPR Gene and Obesity in Patients Using Antipsychotic Medication , 2009, Journal of clinical psychopharmacology.

[50]  D. Vancampfort,et al.  Metabolic syndrome in people with schizophrenia: a review , 2009, World psychiatry : official journal of the World Psychiatric Association.

[51]  J. Waage,et al.  Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver , 2009, Psychopharmacology.

[52]  J. Reginster,et al.  A cross-sectional evaluation of adiponectin plasma levels in patients with schizophrenia and schizoaffective disorder , 2008, Schizophrenia Research.

[53]  S. Cooper,et al.  Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia. , 2008, The British journal of psychiatry : the journal of mental science.

[54]  Zhi-jun Zhang,et al.  [-2548G/A functional polymorphism in the promoter region of leptin gene and antipsychotic agent-induced weight gain in schizophrenic patients: a study of nuclear family-based association]. , 2008, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences.

[55]  D. Jeste,et al.  Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin , 2008, Schizophrenia Research.

[56]  A. Elias,et al.  Abnormalities in glucose metabolism in patients with schizophrenia treated with atypical antipsychotic medications. , 2008, The American journal of medicine.

[57]  J. Olié,et al.  Leptin and Ghrelin Levels in Patients With Schizophrenia During Different Antipsychotics Treatment: A Review , 2007, Schizophrenia bulletin.

[58]  P. Chen,et al.  Increased Plasma Leptin in Antipsychotic-Naïve Females with Schizophrenia, but Not in Males , 2008, Neuropsychobiology.

[59]  Y. Liou,et al.  Adiponectin as a potential biomarker for the metabolic syndrome in Chinese patients taking clozapine for schizophrenia. , 2007, The Journal of clinical psychiatry.

[60]  M. Laakso,et al.  Association of C-Reactive Protein, Interleukin-1 Receptor Antagonist and Adiponectin with the Metabolic Syndrome , 2007, Mediators of inflammation.

[61]  B. Franke,et al.  The association between HTR2C polymorphisms and obesity in psychiatric patients using antipsychotics: a cross-sectional study , 2007, The Pharmacogenomics Journal.

[62]  B. Franke,et al.  The Association Between HTR2C Gene Polymorphisms and the Metabolic Syndrome in Patients With Schizophrenia , 2007, Journal of clinical psychopharmacology.

[63]  Y. Kesäniemi,et al.  Low plasma adiponectin concentration is an indicator of the metabolic syndrome. , 2006, European journal of endocrinology.

[64]  G. Reynolds,et al.  The 5-HT2C receptor and antipsychoticinduced weight gain – mechanisms and genetics , 2006, Journal of psychopharmacology.

[65]  F. Newell,et al.  Olanzapine Treatment is Associated with Reduced High Molecular Weight Adiponectin in Serum: A Potential Mechanism for Olanzapine-induced Insulin Resistance in Patients with Schizophrenia , 2006, Journal of clinical psychopharmacology.

[66]  K. Zavitsanou,et al.  Neuropeptide Y mRNA expression levels following chronic olanzapine, clozapine and haloperidol administration in rats , 2006, Neuropeptides.

[67]  M. Laakso,et al.  Common polymorphisms (single-nucleotide polymorphisms SNP+45 and SNP+276) of the adiponectin gene regulate serum adiponectin concentrations and blood pressure in young Finnish men. , 2006, Molecular genetics and metabolism.

[68]  G. Reynolds,et al.  Clozapine, but not haloperidol, increases neuropeptide Y neuronal expression in the rat hypothalamus , 2006, Journal of psychopharmacology.

[69]  T. Tanioka,et al.  Gender differences in association of plasma adiponectin with obesity reflect resultant insulin resistance in non‐diabetic Japanese patients with schizophrenia , 2005, Psychiatry and clinical neurosciences.

[70]  G. Fantuzzi.  Adipose tissue, adipokines, and inflammation. , 2005, The Journal of allergy and clinical immunology.

[71]  Del D. Miller,et al.  Clozapine‐induced weight gain associated with the 5HT2C receptor −759C/T polymorphism , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[72]  J. Newcomer.  Second-Generation (Atypical) Antipsychotics and Metabolic Effects , 2005, CNS drugs.

[73]  K. Kosaka,et al.  Serum adiponectin concentrations during treatment with olanzapine or risperidone: a pilot study , 2004, International clinical psychopharmacology.

[74]  Zhi-jun Zhang,et al.  [Association of -2548G/A functional polymorphism in the promoter region of leptin gene with antipsychotic agent-induced weight gain]. , 2003, Zhonghua yi xue za zhi.

[75]  P. Fitzgerald,et al.  The relationship of changes in leptin, neuropeptide Y and reproductive hormones to antipsychotic induced weight gain , 2003, Human psychopharmacology.

[76]  C. Bouchard,et al.  Genetic variation at the adipsin locus and response to long-term overfeeding , 2003, European Journal of Clinical Nutrition.

[77]  P. Sparén,et al.  Mortality and causes of death in schizophrenia in Stockholm County, Sweden , 2000, Schizophrenia Research.

[78]  W D Plummer,et al.  Power and sample size calculations for studies involving linear regression. , 1998, Controlled clinical trials.

[79]  E. Ravussin,et al.  Concentrations of adipsin in blood and rates of adipsin secretion by adipose tissue in humans with normal, elevated and diminished adipose tissue mass. , 1994, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[80]  B. Spiegelman,et al.  Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. , 1992, The Journal of biological chemistry.